BLISSGVS Q1 FY27 results at a glance
BLISS GVS PHARMA LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹286 cr |
|---|
| Revenue YoY | +37.6% |
|---|
| Operating profit | ₹66.46 cr |
|---|
| Operating margin | 23.3% |
|---|
| Net profit | ₹50.1 cr |
|---|
| Net profit YoY | +16.4% |
|---|
| Net profit QoQ | +40.8% |
|---|
| Net margin | 17.5% |
|---|
| Basic EPS | ₹4.73 |
|---|
| TTM revenue | ₹1,005 cr |
|---|
| TTM net profit | ₹136 cr |
|---|
| TTM net margin | 13.5% |
|---|
BLISSGVS Q1 FY27 results: what the numbers say
BLISS GVS PHARMA LTD (BLISSGVS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹286 cr and a net profit of ₹50.1 cr, translating into earnings per share of ₹4.73.
Compared with the same quarter a year earlier, revenue grew strongly by +37.6% and net profit grew by +16.4%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹66.46 cr, an operating margin of 23.3% versus 16.0% a year ago — a gain of 7.3 percentage points.
BLISSGVS quarter-wise results table
Net profit
₹50.1 cr
+16.4% YoY
Operating profit
₹66.46 cr
+100.6% YoY
BLISS GVS PHARMA LTD (BLISSGVS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹286 cr | ₹66.46 cr | ₹50.1 cr | 23.3% | 17.5% | ₹4.73 | +16.4% | +40.8% |
| Q4 FY262026-03-31 | ₹257 cr | ₹35.77 cr | ₹35.58 cr | 13.9% | 13.8% | ₹3.27 | — | +52.9% |
| Q3 FY262025-12-31 | ₹218 cr | ₹26.44 cr | ₹23.27 cr | 12.1% | 10.7% | ₹2.20 | — | -14.6% |
| Q2 FY262025-09-30 | ₹244 cr | ₹23.5 cr | ₹27.25 cr | 9.6% | 11.1% | ₹2.58 | — | -36.7% |
| Q1 FY262025-06-30 | ₹207 cr | ₹33.13 cr | ₹43.04 cr | 16.0% | 20.7% | ₹4.08 | — | — |
| TTM (last 4 quarters) | ₹1,005 cr | ₹152 cr | ₹136 cr | 15.1% | 13.5% | ₹12.78 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
BLISSGVS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
BLISS GVS PHARMA LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹286 cr | ₹257 cr | ₹218 cr | ₹244 cr | ₹207 cr |
|---|
| Total expenses | ₹219 cr | ₹221 cr | ₹192 cr | ₹221 cr | ₹174 cr |
|---|
| Gross profit | ₹171 cr | ₹144 cr | ₹117 cr | ₹126 cr | ₹116 cr |
|---|
| Operating profit (EBIT) | ₹66.46 cr | ₹35.77 cr | ₹26.44 cr | ₹23.5 cr | ₹33.13 cr |
|---|
| Operating margin | 23.3% | 13.9% | 12.1% | 9.6% | 16.0% |
|---|
| Interest cost | ₹0.58 cr | ₹2.01 cr | ₹1.49 cr | ₹3.04 cr | ₹5.47 cr |
|---|
| Profit before tax | ₹75.48 cr | ₹44.95 cr | ₹40.9 cr | ₹40.63 cr | ₹63.11 cr |
|---|
| Tax expense | ₹24.11 cr | ₹7.95 cr | ₹16.12 cr | ₹12.04 cr | ₹18.75 cr |
|---|
| Effective tax rate | 31.9% | 17.7% | 39.4% | 29.6% | 29.7% |
|---|
| Net profit (PAT) | ₹50.1 cr | ₹35.58 cr | ₹23.27 cr | ₹27.25 cr | ₹43.04 cr |
|---|
| Net profit margin | 17.5% | 13.8% | 10.7% | 11.1% | 20.7% |
|---|
| Basic EPS | ₹4.73 | ₹3.27 | ₹2.20 | ₹2.58 | ₹4.08 |
|---|
| Diluted EPS | ₹4.65 | ₹3.27 | ₹2.14 | ₹2.54 | ₹4.04 |
|---|
BLISSGVS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +37.6% | — | — | — | — |
|---|
| Revenue QoQ | +11.1% | +17.8% | -10.7% | +17.8% | — |
|---|
| Operating profit YoY | +100.6% | — | — | — | — |
|---|
| Operating profit QoQ | +85.8% | +35.3% | +12.5% | -29.1% | — |
|---|
| Net profit YoY | +16.4% | — | — | — | — |
|---|
| Net profit QoQ | +40.8% | +52.9% | -14.6% | -36.7% | — |
|---|
| EPS YoY | +15.9% | — | — | — | — |
|---|
| EPS QoQ | +44.6% | +48.6% | -14.7% | -36.8% | — |
|---|
BLISSGVS annual results history
Full-year performance for BLISS GVS PHARMA LTD, useful for reading each quarter in context.
BLISS GVS PHARMA LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹921 cr | ₹802 cr | ₹766 cr | ₹747 cr |
|---|
| Total expenses | ₹762 cr | ₹704 cr | ₹631 cr | ₹647 cr |
|---|
| Gross profit | ₹496 cr | ₹388 cr | ₹384 cr | ₹346 cr |
|---|
| Operating profit (EBIT) | ₹159 cr | ₹97.76 cr | ₹135 cr | ₹101 cr |
|---|
| Operating margin | 17.3% | 12.2% | 17.6% | 13.5% |
|---|
| Interest cost | ₹3.71 cr | ₹6.18 cr | ₹5.56 cr | ₹3.24 cr |
|---|
| Profit before tax | ₹190 cr | ₹126 cr | ₹117 cr | ₹106 cr |
|---|
| Tax expense | ₹54.86 cr | ₹35.38 cr | ₹35.29 cr | ₹29.34 cr |
|---|
| Effective tax rate | 28.9% | 28.2% | 30.2% | 27.7% |
|---|
| Net profit (PAT) | ₹129 cr | ₹84.3 cr | ₹75.45 cr | ₹70.86 cr |
|---|
| Net profit margin | 14.0% | 10.5% | 9.9% | 9.5% |
|---|
| Basic EPS | ₹12.23 | ₹8.02 | ₹7.23 | ₹6.83 |
|---|
| Diluted EPS | ₹12.00 | ₹7.95 | ₹7.11 | ₹6.72 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹286 cr against ₹207 cr in Q1 FY26, and ₹257 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +11.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹219 cr, or 76.7% of revenue, with operating profit grew +100.6% year on year.
Margins, tax and profitability
Net profit of ₹50.1 cr works out to a net margin of 17.5% compared with 20.7% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, BLISS GVS PHARMA LTD reported profit before tax of ₹75.48 cr, a tax charge of ₹24.11 cr (effective rate 31.9%), interest cost of ₹0.58 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹35.58 cr in Q4 FY26 to ₹50.1 cr in Q1 FY27, a change of +40.8%.
Trailing twelve months and annual context
Across the trailing four quarters BLISS GVS PHARMA LTD has generated revenue of ₹1,005 cr and net profit of ₹136 cr, a trailing net margin of 13.5%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹921 cr with net profit of ₹129 cr and EPS of ₹12.23, versus the prior year where revenue grew +14.8% and profit grew +53.2%.
What to watch in the next BLISSGVS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
BLISS GVS PHARMA LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
BLISSGVS results coverage
No results report published for BLISSGVS yet — our desk covers each quarter within minutes of the filing.
BLISSGVS quarterly results FAQs
What were BLISS GVS PHARMA LTD (BLISSGVS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), BLISS GVS PHARMA LTD reported revenue of ₹286 cr and net profit of ₹50.1 cr, a change of +16.4% year on year on +37.6% revenue growth. EPS stood at ₹4.73.
What is BLISSGVS profit margin in Q1 FY27?
BLISS GVS PHARMA LTD posted a net profit margin of 17.5% and an operating margin of 23.3% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,005 cr and net profit ₹136 cr.
Did BLISSGVS results beat the previous quarter?
BLISS GVS PHARMA LTD net profit changed +40.8% quarter on quarter, from ₹35.58 cr in Q4 FY26 to ₹50.1 cr in Q1 FY27.
When are BLISS GVS PHARMA LTD (BLISSGVS) quarterly results?
BLISS GVS PHARMA LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see BLISSGVS latest quarterly results?
Results coverage for BLISSGVS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the BLISSGVS stock page.
What is BLISS GVS PHARMA LTD annual revenue and profit?
For FY26, BLISS GVS PHARMA LTD reported full-year revenue of ₹921 cr and net profit of ₹129 cr, with EPS of ₹12.23.
How many quarterly results has BLISSGVS declared recently?
Past results dates for BLISSGVS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
